PetMed Express Company Profile (NASDAQ:PETS)

About PetMed Express (NASDAQ:PETS)

PetMed Express logoPetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Retail - Drugs without Grocery
  • Sub-Industry: Internet Retail
  • Symbol: NASDAQ:PETS
  • CUSIP: 71638210
  • Web: www.1800petmeds.com
Capitalization:
  • Market Cap: $737.84 million
  • Outstanding Shares: 20,292,000
Average Prices:
  • 50 Day Moving Avg: $40.97
  • 200 Day Moving Avg: $33.60
  • 52 Week Range: $18.90 - $50.90
P/E:
  • Trailing P/E Ratio: 27.19
  • Foreward P/E Ratio: 23.41
  • P/E Growth: 2.53
Sales & Book Value:
  • Annual Revenue: $256.35 million
  • Price / Sales: 2.80
  • Book Value: $4.88 per share
  • Price / Book: 7.24
Dividend:
  • Annual Dividend: $0.80
  • Dividend Yield: 2.2%
Profitability:
  • EBIDTA: $43.21 million
  • Net Margins: 10.34%
  • Return on Equity: 28.67%
  • Return on Assets: 24.50%
Debt:
  • Current Ratio: 3.71%
  • Quick Ratio: 2.81%
Misc:
  • Average Volume: 1.10 million shs.
  • Beta: 1.03
  • Short Ratio: 4.22
 

Frequently Asked Questions for PetMed Express (NASDAQ:PETS)

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express declared a quarterly dividend on Monday, July 24th. Shareholders of record on Monday, August 7th will be paid a dividend of $0.20 per share on Friday, August 18th. This represents a $0.80 annualized dividend and a yield of 2.26%. The ex-dividend date is Thursday, August 3rd. View PetMed Express' Dividend History.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) announced its earnings results on Monday, July, 24th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.07. The business earned $79.66 million during the quarter, compared to analysts' expectations of $77.32 million. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The company's quarterly revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.32 EPS. View PetMed Express' Earnings History.

When will PetMed Express make its next earnings announcement?

PetMed Express is scheduled to release their next quarterly earnings announcement on Monday, October, 23rd 2017. View Earnings Estimates for PetMed Express.

Where is PetMed Express' stock going? Where will PetMed Express' stock price be in 2017?

4 brokers have issued 1 year target prices for PetMed Express' shares. Their predictions range from $40.00 to $54.00. On average, they expect PetMed Express' share price to reach $47.00 in the next year. View Analyst Ratings for PetMed Express.

Are investors shorting PetMed Express?

PetMed Express saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 6,576,207 shares, an increase of 105.9% from the August 15th total of 3,193,474 shares. Based on an average daily volume of 3,090,918 shares, the short-interest ratio is currently 2.1 days. Currently, 33.3% of the shares of the company are sold short.

Who are some of PetMed Express' key competitors?

Who are PetMed Express' key executives?

PetMed Express' management team includes the folowing people:

  • Robert C. Schweitzer, Independent Chairman of the Board
  • Menderes Akdag, President, Chief Executive Officer, Director
  • Bruce S. Rosenbloom, Chief Financial Officer, Treasurer
  • Frank J. Formica, Independent Director
  • Gian M. Fulgoni, Independent Director
  • Ronald J. Korn, Independent Director

Who owns PetMed Express stock?

PetMed Express' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.15%), Renaissance Technologies LLC (8.12%), Vanguard Group Inc. (6.41%), Dimensional Fund Advisors LP (4.24%), State Street Corp (3.19%) and Acadian Asset Management LLC (2.27%). Company insiders that own PetMed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for PetMed Express.

Who sold PetMed Express stock? Who is selling PetMed Express stock?

PetMed Express' stock was sold by a variety of institutional investors in the last quarter, including Uniplan Investment Counsel Inc., Numeric Investors LLC, Renaissance Technologies LLC, LSV Asset Management, TD Asset Management Inc., Wells Fargo & Company MN, Rothschild Investment Corp IL and BlackRock Inc.. Company insiders that have sold PetMed Express stock in the last year include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for PetMed Express.

Who bought PetMed Express stock? Who is buying PetMed Express stock?

PetMed Express' stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Oaktop Capital Management II L.P., Vanguard Group Inc., Koch Industries Inc., Lord Abbett & CO. LLC, EAM Investors LLC, WBI Investments Inc. and Prudential Financial Inc.. View Insider Buying and Selling for PetMed Express.

How do I buy PetMed Express stock?

Shares of PetMed Express can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PetMed Express' stock price today?

One share of PetMed Express stock can currently be purchased for approximately $35.35.


MarketBeat Community Rating for PetMed Express (NASDAQ PETS)
Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  167
MarketBeat's community ratings are surveys of what our community members think about PetMed Express and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for PetMed Express (NASDAQ:PETS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $47.00 (32.96% upside)

Analysts' Ratings History for PetMed Express (NASDAQ:PETS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/24/2017SidotiUpgradeNeutral -> Buy$47.00HighView Rating Details
8/21/2017Craig HallumReiterated RatingHold$43.00 -> $40.00HighView Rating Details
7/26/2017Noble FinancialReiterated RatingHoldLowView Rating Details
7/24/2017Northcoast ResearchUpgradeNeutral -> Buy$54.00HighView Rating Details
8/16/2016Credit Suisse GroupReiterated RatingSell$13.00N/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for PetMed Express (NASDAQ:PETS)
Earnings by Quarter for PetMed Express (NASDAQ:PETS)
Earnings History by Quarter for PetMed Express (NASDAQ PETS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/23/2017$0.31N/AView Earnings Details
7/24/2017Q1 2018$0.38$0.45$77.32 million$79.66 millionViewN/AView Earnings Details
5/8/2017Q4 17$0.26$0.37$56.53 million$63.03 millionViewListenView Earnings Details
1/23/2017Q3 2017$0.25$0.24$52.70 million$52.90 millionViewN/AView Earnings Details
10/24/2016Q2$0.26$0.24$58.47 million$60.80 millionViewN/AView Earnings Details
7/25/2016Q1$0.31$0.32$72.90 million$72.49 millionViewN/AView Earnings Details
5/9/2016Q4$0.25$0.27$50.20 million$55.40 millionViewN/AView Earnings Details
1/25/2016Q316$0.25$0.24$49.28 million$50.90 millionViewListenView Earnings Details
10/19/2015Q216$0.20$0.22$58.34 million$56.70 millionViewListenView Earnings Details
7/20/2015Q116$0.28$0.29$73.04 million$71.60 millionViewN/AView Earnings Details
5/4/2015Q415$0.25$0.25$49.11 million$50.00 millionViewN/AView Earnings Details
1/20/2015Q315$0.24$0.24$49.26 million$49.30 millionViewN/AView Earnings Details
10/20/2014Q215$0.21$0.19$61.22 million$57.60 millionViewListenView Earnings Details
7/21/2014Q115$0.25$0.25$74.25 million$72.50 millionViewN/AView Earnings Details
5/5/2014Q414$0.22$0.23$55.02 million$48.60 millionViewN/AView Earnings Details
1/21/2014Q214$0.23$0.23$52.06 million$50.10 millionViewN/AView Earnings Details
10/21/2013Q213$0.22$0.20$60.33 million$80.50 millionViewN/AView Earnings Details
7/22/2013Q1 2013$0.22$0.24$69.55 million$74.20 millionViewN/AView Earnings Details
5/6/2013Q4 2012$0.21$0.23$55.31 million$51.10 millionViewN/AView Earnings Details
1/22/2013Q3 2012$0.17$0.23$49.97 million$49.60 millionViewN/AView Earnings Details
10/22/2012$0.17$0.20ViewN/AView Earnings Details
7/23/2012$0.23$0.20ViewN/AView Earnings Details
5/7/2012$0.18$0.20ViewN/AView Earnings Details
1/23/2012$0.16$0.19ViewN/AView Earnings Details
10/24/2011$0.15$0.19ViewN/AView Earnings Details
7/18/2011$0.24$0.22ViewN/AView Earnings Details
5/9/2011$0.23$0.19ViewN/AView Earnings Details
1/24/2011$0.20$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PetMed Express (NASDAQ:PETS)
2017 EPS Consensus Estimate: $1.06
2018 EPS Consensus Estimate: $1.36
2019 EPS Consensus Estimate: $1.51
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.30$0.30$0.30
Q2 20172$0.23$0.28$0.26
Q3 20172$0.23$0.26$0.25
Q4 20172$0.25$0.26$0.26
Q1 20182$0.40$0.40$0.40
Q2 20182$0.28$0.28$0.28
Q3 20182$0.27$0.29$0.28
Q4 20182$0.38$0.41$0.40
Q1 20192$0.47$0.49$0.48
Q2 20192$0.30$0.30$0.30
Q3 20192$0.29$0.31$0.30
Q4 20192$0.40$0.45$0.43
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for PetMed Express (NASDAQ:PETS)
Most Recent Dividend:8/18/2017
Annual Dividend:$0.80
Dividend Yield:2.26%
Payout Ratio:61.54% (Trailing 12 Months of Earnings)
56.74% (Based on This Year's Estimates)
52.98% (Based on Next Year's Estimates)
Dividend Payments by Quarter for PetMed Express (NASDAQ:PETS)

Dividend History by Quarter for PetMed Express (NASDAQ PETS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/24/2017quarterly$0.201.66%8/3/20178/7/20178/18/2017
5/8/2017quarterly$0.205/17/20175/19/20175/26/2017
1/23/2017quarterly$0.193.61%2/2/20172/6/20172/17/2017
10/24/2016quarterly$0.193.84%11/3/201611/7/201611/18/2016
7/25/2016quarterly$0.193.71%8/4/20168/8/20168/19/2016
5/9/2016quarterly$0.193.9%5/18/20165/20/20165/27/2016
1/25/2016quarterly$0.184.04%2/4/20162/8/20162/19/2016
10/19/2015quarterly$0.184.28%10/29/201511/2/201511/13/2015
7/20/2015quarterly$0.184.23%7/30/20158/3/20158/14/2015
5/4/2015quarterly$0.184.41%5/13/20155/15/20155/22/2015
1/20/2015quarterly$0.174.2%1/30/20152/3/20152/13/2015
10/20/2014quarterly$0.1710/30/201411/3/201411/14/2014
7/21/2014quarterly$0.174.79%7/31/20148/4/20148/15/2014
5/5/2014quarterly$0.175.22%5/14/20145/16/20145/23/2014
1/30/2014quarterly$0.175.14%2/10/20142/12/20142/21/2014
10/28/2013quarterly$0.174.56%11/6/201311/8/201311/22/2013
7/26/2013quarterly$0.174.16%8/8/20138/12/20138/23/2013
5/3/2013quarterly$0.154.65%5/13/20135/15/20135/24/2013
1/28/2013quarterly$0.154.64%2/6/20132/8/20132/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for PetMed Express (NASDAQ:PETS)
Insider Ownership Percentage: 4.00%
Institutional Ownership Percentage: 78.91%
Insider Trades by Quarter for PetMed Express (NASDAQ:PETS)
Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)
Insider Trades by Quarter for PetMed Express (NASDAQ:PETS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/1/2017Robert C SchweitzerDirectorSell2,500$49.18$122,950.00View SEC Filing  
7/28/2017Ronald J KornDirectorSell5,000$48.18$240,900.00View SEC Filing  
7/27/2017Bruce S RosenbloomCFOSell6,833$50.18$342,879.94View SEC Filing  
7/27/2017Robert C SchweitzerDirectorSell5,000$48.60$243,000.00View SEC Filing  
5/16/2017Frank J FormicaDirectorSell5,000$35.32$176,600.00View SEC Filing  
5/10/2017Gian FulgoniDirectorSell35,000$32.22$1,127,700.00View SEC Filing  
5/8/2017Bruce S RosenbloomInsiderSell9,000$27.00$243,000.00View SEC Filing  
5/1/2017Bruce S RosenbloomInsiderSell1,500$24.00$36,000.00View SEC Filing  
12/13/2016Menderes AkdagCEOSell10,000$23.00$230,000.00View SEC Filing  
12/9/2016Bruce S RosenbloomInsiderSell1,500$23.00$34,500.00View SEC Filing  
12/7/2016Menderes AkdagCEOSell3,107$22.75$70,684.25View SEC Filing  
11/25/2016Menderes AkdagCEOSell6,274$22.25$139,596.50View SEC Filing  
11/16/2016Frank J FormicaDirectorSell10,000$21.75$217,500.00View SEC Filing  
11/14/2016Bruce S RosenbloomInsiderSell3,000$21.75$65,250.00View SEC Filing  
11/14/2016Menderes AkdagCEOSell40,000$21.63$865,200.00View SEC Filing  
10/10/2016Bruce S RosenbloomInsiderSell1,500$21.00$31,500.00View SEC Filing  
10/10/2016Menderes AkdagCEOSell10,000$21.00$210,000.00View SEC Filing  
9/22/2016Menderes AkdagCEOSell10,000$20.75$207,500.00View SEC Filing  
8/12/2016Bruce S RosenbloomInsiderSell8,000$20.38$163,040.00View SEC Filing  
8/11/2016Robert C SchweitzerDirectorSell3,000$20.59$61,770.00View SEC Filing  
8/9/2016Robert C SchweitzerDirectorSell4,500$20.52$92,340.00View SEC Filing  
8/1/2016Ronald J KornDirectorSell4,000$20.76$83,040.00View SEC Filing  
5/9/2016Bruce S RosenbloomCFOSell5,500$19.54$107,470.00View SEC Filing  
3/30/2016Bruce S RosenbloomCFOSell1,500$18.00$27,000.00View SEC Filing  
3/14/2016Bruce S RosenbloomCFOSell3,000$17.25$51,750.00View SEC Filing  
2/22/2016Ronald J KornDirectorSell5,000$16.76$83,800.00View SEC Filing  
1/22/2016Bruce S RosenbloomCFOSell750$18.50$13,875.00View SEC Filing  
11/20/2015Ronald J KornDirectorSell1,000$17.01$17,010.00View SEC Filing  
7/14/2015Bruce S RosenbloomCFOSell400$18.25$7,300.00View SEC Filing  
7/13/2015Bruce S RosenbloomCFOSell100$18.25$1,825.00View SEC Filing  
6/19/2015Bruce S RosenbloomCFOSell1,000$17.88$17,880.00View SEC Filing  
6/19/2015Menderes AkdagCEOSell8,000$17.75$142,000.00View SEC Filing  
6/4/2015Menderes AkdagCEOSell9,930$17.50$173,775.00View SEC Filing  
5/8/2015Frank J FormicaDirectorSell7,500$16.51$123,825.00View SEC Filing  
4/23/2015Menderes AkdagCEOSell10,000$17.25$172,500.00View SEC Filing  
4/20/2015Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
4/13/2015Menderes AkdagCEOSell7,499$16.75$125,608.25View SEC Filing  
4/13/2015Ronald J KornDirectorSell2,000$16.75$33,500.00View SEC Filing  
4/8/2015Menderes AkdagCEOSell2,501$16.75$41,891.75View SEC Filing  
3/30/2015Menderes AkdagCEOSell10,000$16.50$165,000.00View SEC Filing  
3/25/2015Ronald J KornDirectorSell2,000$16.25$32,500.00View SEC Filing  
1/21/2015Menderes AkdagCEOSell60,000$15.63$937,800.00View SEC Filing  
1/20/2015Bruce S RosenbloomCFOSell2,167$15.40$33,371.80View SEC Filing  
8/15/2014Ronald J KornDirectorSell2,000$14.13$28,260.00View SEC Filing  
7/22/2014Bruce S RosenbloomCFOSell1,000$14.13$14,130.00View SEC Filing  
7/21/2014Bruce S RosenbloomCFOSell500$14.00$7,000.00View SEC Filing  
6/12/2014Bruce S RosenbloomCFOSell1,500$13.50$20,250.00View SEC Filing  
9/13/2013Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
9/11/2013Bruce S RosenbloomCFOSell6,666$16.21$108,055.86View SEC Filing  
8/14/2013Ronald KornDirectorSell1,000$16.25$16,250.00View SEC Filing  
8/12/2013Ronald KornDirectorSell1,000$16.18$16,180.00View SEC Filing  
7/31/2013Frank J FormicaDirectorSell7,000$16.39$114,730.00View SEC Filing  
7/22/2013Bruce S RosenbloomCFOSell6,250$16.74$104,625.00View SEC Filing  
3/6/2013Ronald J KornDirectorSell2,000$13.50$27,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for PetMed Express (NASDAQ:PETS)
Latest Headlines for PetMed Express (NASDAQ:PETS)
Source:
DateHeadline
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In PetMed Express, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - September 20 at 7:39 AM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline - October 24, 2017
finance.yahoo.com - September 19 at 6:28 AM
americanbankingnews.com logoPetMed Express, Inc. (PETS) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - September 18 at 2:44 AM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline - October 24, 2017
finance.yahoo.com - September 17 at 6:46 AM
finance.yahoo.com logoAt $36.71, Is PetMed Express Inc (PETS) A Buy?
finance.yahoo.com - September 17 at 6:46 AM
americanbankingnews.com logoQ2 2018 EPS Estimates for PetMed Express, Inc. Cut by Northcoast Research (PETS)
www.americanbankingnews.com - September 15 at 12:58 PM
americanbankingnews.com logoPetMed Express, Inc. (PETS) Short Interest Up 105.9% in August
www.americanbankingnews.com - September 14 at 1:46 AM
businesswire.com logoBragar Eagel & Squire, P.C. Reminds Investors That a Class Action ... - Business Wire (press release)
www.businesswire.com - September 12 at 8:30 AM
globenewswire.com logoPETMED SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100000 of ... - GlobeNewswire (press release)
globenewswire.com - September 10 at 6:23 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PetMed Express, Inc. of Class Action Lawsuit and Upcoming Deadline - PETS
finance.yahoo.com - September 10 at 6:23 AM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline: October 24, 2017
finance.yahoo.com - September 9 at 7:17 AM
finance.yahoo.com logoPETS LOSS NOTICE: Rosen Law Firm Reminds PetMed Express, Inc. Investors of Important Deadline in Class Action – PETS
finance.yahoo.com - September 9 at 7:17 AM
finance.yahoo.com logoPetMed Express, Inc. : PETS-US: Dividend Analysis : August 07th, 2017 (record date) : By the numbers : September 9, 2017
finance.yahoo.com - September 9 at 7:17 AM
feeds.benzinga.com logoPETMED SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PetMed Express, Inc. - (PETS)
feeds.benzinga.com - September 8 at 11:58 PM
feeds.benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PetMed Express, Inc. and Certain Officers – PETS
feeds.benzinga.com - September 7 at 6:54 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In PetMed Express, Inc. (Nasdaq:PETS) To Contact Brower Piven Before The Lead Plaintiff Deadline
finance.yahoo.com - September 7 at 7:35 AM
americanbankingnews.com logo Analysts Expect Petmed Express Inc (PETS) Will Post Quarterly Sales of $64.53 Million
www.americanbankingnews.com - September 7 at 2:00 AM
finance.yahoo.com logoWhy PetMed Express Inc.'s Shares Plunged in August
finance.yahoo.com - September 5 at 5:13 PM
fool.com logoWhy PetMed Express Inc.'s Shares Plunged in August
www.fool.com - September 5 at 10:19 AM
americanbankingnews.com logoValuEngine Upgrades PetMed Express, Inc. (PETS) to Buy
www.americanbankingnews.com - September 2 at 6:20 PM
finanznachrichten.de logoPETMED EXPRESS INC
www.finanznachrichten.de - September 2 at 7:23 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline: October 24, 2017
finance.yahoo.com - September 2 at 7:23 AM
bizjournals.com logoTechnical Snapshots for these Drug Delivery Stocks -- Delcath Systems, Valeant Pharma, PetMed Express, and Adamis Pharma
www.bizjournals.com - September 1 at 7:12 AM
finance.yahoo.com logoINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of PetMed Express, Inc. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - August 31 at 8:41 AM
finance.yahoo.com logoFederman & Sherwood Announces Filing of Securities Class Action Lawsuit Against PetMed Express, Inc.
finance.yahoo.com - August 30 at 7:55 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline: October 24, 2017
finance.yahoo.com - August 30 at 7:55 AM
finance.yahoo.com logoPETMED SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PetMed Express, Inc. - (PETS)
finance.yahoo.com - August 30 at 7:55 AM
finance.yahoo.com logoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against PetMed Express, Inc. (PETS)
finance.yahoo.com - August 30 at 7:55 AM
feeds.benzinga.com logoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against PetMed Express, Inc. (PETS)
feeds.benzinga.com - August 29 at 8:49 PM
feeds.benzinga.com logoFederman & Sherwood Announces Filing of Securities Class Action Lawsuit Against PetMed Express, Inc.
feeds.benzinga.com - August 29 at 3:49 PM
finance.yahoo.com logoETFs with exposure to PetMed Express, Inc. : August 28, 2017
finance.yahoo.com - August 29 at 6:37 AM
finance.yahoo.com logoWhy Is PetMed (PETS) Up 16.6% Since the Last Earnings Report? - Yahoo Finance
finance.yahoo.com - August 27 at 5:42 AM
bizjournals.com logoPETS Investor Alert: Hagens Berman Alerts Investors in PetMed Express of Investigation into Possible Securities Law Violations
www.bizjournals.com - August 26 at 8:14 AM
streetinsider.com logoPetMed Express (PETS) Releases Further Information Contradicting Short Report
www.streetinsider.com - August 26 at 8:14 AM
finance.yahoo.com logoGlancy Prongay & Murray Files a Securities Class Action on Behalf of PetMed Express, Inc. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - August 26 at 8:14 AM
finance.yahoo.com logoINVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of PetMed Express, Inc. Investors
finance.yahoo.com - August 25 at 9:55 AM
finance.yahoo.com logoPetMed Express D/B/A 1-800-PetMeds Releases Further Information Contradicting the Defamatory Anonymous “Report”
finance.yahoo.com - August 25 at 9:55 AM
finance.yahoo.com logoOnline pet pharmacy fires back at short-seller’s accusation that it’s exploiting opioid epidemic
finance.yahoo.com - August 25 at 9:55 AM
americanbankingnews.com logoPetMed Express, Inc. (PETS) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - August 24 at 12:02 PM
nasdaq.com logoAZRX To Report Data In Sep., Long & Short Of PETS, IMUC Plunges, CLDX On Watch - Nasdaq
www.nasdaq.com - August 24 at 10:57 AM
nasdaq.com logoWhy Is PetMed (PETS) Up 16.6% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - August 24 at 10:57 AM
prnewswire.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS - PR Newswire (press release)
www.prnewswire.com - August 24 at 10:57 AM
seekingalpha.com logoPetMed Express continues slide, down 14% - Seeking Alpha
seekingalpha.com - August 24 at 10:57 AM
finance.yahoo.com logoPETMED INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates PetMed Express, Inc. for Possible Securities Fraud - (PETS)
finance.yahoo.com - August 24 at 10:56 AM
finance.yahoo.com logoWhy Is PetMed (PETS) Up 16.6% Since the Last Earnings Report?
finance.yahoo.com - August 24 at 10:56 AM
finance.yahoo.com logoIs the Options Market Predicting a Spike in PetMed (PETS) Stock?
finance.yahoo.com - August 24 at 10:56 AM
americanbankingnews.com logoPetMed Express, Inc. (PETS) Upgraded by Sidoti to Buy
www.americanbankingnews.com - August 24 at 10:56 AM
finance.yahoo.com logoFaruqi & Faruqi, LLP is Investigating PetMed Express, Inc. (PETS) on Behalf of its Shareholders
finance.yahoo.com - August 24 at 10:56 AM
seekingalpha.com logoPetMed Express takes issue with "false and defamatory" report; stock rebounds 15% from session low
seekingalpha.com - August 23 at 3:34 PM
benzinga.com logoJim Cramer Gives His Opinion On Advance Auto Parts And Petmed Express - Benzinga
www.benzinga.com - August 23 at 10:13 AM

Social

Chart

PetMed Express (PETS) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff